Congenital Anomalies & Birth Defects

1Definition & Core Concepts

A congenital anomaly is any structural or functional abnormality present at birth, whether causative of clinical features or found incidentally. Anomalies may be apparent at delivery or detected later in life.

Global Prevalence

2–3% of all live births — major anomalies worldwide
5–7% in GCC countries (elevated due to consanguinity)
Leading cause of neonatal & infant mortality globally
Present in ~20% of all perinatal deaths

Major vs Minor Anomalies

Major: significant medical, surgical or social consequence (e.g., CHD, myelomeningocele)
Minor: no serious clinical significance alone but may indicate an underlying syndrome (e.g., single palmar crease, auricular tag)
3+ minor anomalies → increased probability of a major anomaly

CClassification of Congenital Anomalies

Structural Anomalies

Cardiac (CHD) Neural Tube Defects Cleft Lip/Palate Limb Defects Renal Anomalies Gastrointestinal Abdominal Wall

Detectable by imaging / physical examination
Organ formation abnormal in shape, size or position

Functional Anomalies

Chromosomal (Down, Turner) Metabolic (PKU, OA) Neurodevelopmental Haematological (SCD, Thal)

Normal structure but impaired function
Require biochemical or genetic testing to confirm
Detected via newborn bloodspot screening

Pattern Recognition

Term	Definition	Example
Isolated	Single anomaly, no systemic pattern	Isolated cleft lip
Sequence	Series of anomalies caused by one primary event	Pierre Robin sequence (micrognathia → glossoptosis → cleft palate)
Association	Non-random co-occurrence, no proven single cause	VACTERL
Syndrome	Multiple anomalies with a known single cause	Down syndrome (trisomy 21)

VVACTERL Association

VACTERL is an association — not a syndrome. It requires at least 3 of the 7 components for diagnosis. No single causative mutation identified.

Letter	Component	Key Feature
V	Vertebral defects	Segmentation / fusion anomalies
A	Anorectal malformations	Imperforate anus
C	Cardiac defects	VSD most common
TE	Tracheo-Esophageal Fistula	EA with/without TEF
R	Renal anomalies	Renal agenesis, horseshoe kidney
L	Limb defects	Radial aplasia, thumb anomalies

Nursing Implications

Full body examination required when one component found
Cardiac echo & renal USS mandatory
Spine X-ray / MRI
Assess for TEF: inability to pass NGT beyond 10cm, excessive secretions, respiratory distress with feeding
Genetic counselling — recurrence risk low but empirical (~1–3%)

Newborn with imperforate anus: always screen for cardiac, renal, and vertebral anomalies before surgical repair.

TTeratogen Categories

TORCH Infections

Toxoplasmosis — chorioretinitis, hydrocephalus
Other (Syphilis, VZV, Zika)
Rubella — cardiac, cataracts, deafness
CMV — most common; SNHL, microcephaly
HSV — encephalitis, skin lesions

Teratogenic Medications

Thalidomide — phocomelia (limb reduction)
Valproate — NTD, craniofacial, cognitive
Isotretinoin — ear, cardiac, CNS defects
Warfarin — skeletal, nasal hypoplasia
ACE inhibitors — renal dysgenesis (2nd/3rd trimester)
Methotrexate — embryotoxic

Other Teratogens

Alcohol (FASD) — no safe level; facial features, NTD, intellectual disability
Ionising Radiation — microcephaly, leukaemia risk
Maternal Diabetes — cardiac, sacral agenesis, macrosomia
Hyperthermia — NTD risk in first trimester
Maternal PKU — microcephaly, CHD if untreated

Preconception Folic Acid — NTD Prevention

Standard Risk: 400 mcg (0.4 mg) folic acid daily — begin at least 1 month before conception and continue through first trimester. Recommended for ALL women of childbearing age.

High Risk: 5 mg folic acid daily — women with: previous NTD-affected pregnancy, personal/partner NTD history, diabetes, antiepileptics (valproate/carbamazepine), BMI >30, malabsorption syndromes.

NNeural Tube Defects — Overview

NTDs result from failure of the neural tube to close (days 21–28 post-conception). They are among the most common serious congenital anomalies and are largely preventable with adequate folate.

Spina Bifida Spectrum

Occulta: bony defect only; skin intact; often asymptomatic; dimple/hair tuft may be present
Meningocele: meninges herniate through defect; no neural tissue; better prognosis
Myelomeningocele (MMC): meninges + spinal cord/nerves herniate; most severe; causes neurological deficit below lesion level

Cranial NTDs

Anencephaly: absence of cranial vault & cerebral hemispheres; lethal; incompatible with sustained life
Encephalocele: brain/meninges herniate through skull defect; severity depends on contents
Iniencephaly: rare; cervical spine/occiput defect; lethal

Associated Conditions

Chiari II malformation: cerebellar herniation through foramen magnum — in ~80% of MMC
Hydrocephalus: ~90% of MMC patients require VP shunt
Tethered cord syndrome: spinal cord adherent to surrounding tissue — progressive neurological deterioration
Neurogenic bladder & bowel

MMCMyelomeningocele — Immediate Nursing Care

Priority: Protect the sac from rupture, prevent infection, maintain perfusion, keep prone. Latex allergy precautions from day 1 — lifelong latex allergy risk in MMC patients.

Sac Management (Pre-operative)

Cover sac immediately at delivery with sterile non-adherent dressing (e.g., Telfa) moistened with warm normal saline — do NOT allow to dry

Change dressing every 2–4 hours or when soiled; maintain sterile technique at all times

Do NOT apply adhesive dressings directly to sac; do NOT rupture sac; document sac size/colour/integrity

LATEX-FREE environment — use non-latex gloves; label chart; educate family; latex allergy develops in 50% of MMC patients with repeated exposure

Position prone or side-lying to prevent sac pressure; pad bony prominences; avoid nappy over sac

Neurological & Systems Assessment

Lesion level: determines extent of motor/sensory deficit (higher level = greater deficit)
Lower limb: tone, movement, reflexes, response to stimuli below lesion
Temperature regulation: impaired below lesion; use incubator; monitor core temperature
Skin integrity: insensate areas prone to pressure injury — turn frequently, inspect with each care
Urinary output: neurogenic bladder — assess for retention; urological input early
Bowel: neurogenic bowel — document passage of meconium

Surgical closure is usually performed within 24–72 hours of birth to minimise infection and neurological deterioration.

Neurogenic Bladder — CIC Programme

Clean intermittent catheterisation (CIC) is the gold standard management
Begin post-operatively once stabilised; frequency typically every 3–4 hours
Use appropriate catheter size for age/anatomy
Clean (not sterile) technique for home CIC is acceptable and preferred
Teach family before discharge — demonstrate, observe return demo
Monitor for UTI: cloudy/offensive urine, fever, increased spasticity
Urology review every 6–12 months; renal USS annually

Parent Teaching Points:
• Wash hands thoroughly before CIC
• Clean catheter with soap & water; can reuse catheters at home
• Keep a bladder diary (volume drained, times)
• Signs of UTI to report immediately
• Skin inspection — pressure areas, catheter-related trauma
• Never force catheter if resistance felt

HHydrocephalus & VP Shunt Nursing Care

Clinical Features of Hydrocephalus

OFC measurement: plot on centile chart; crossing centile lines upward is a red flag
Bulging fontanelle (full/tense at rest, not crying)
Sunset sign — downward deviation of eyes (sclera visible above iris)
Scalp vein distension; thin, shiny scalp skin
Irritability, high-pitched cry, poor feeding
Widening sutures — Macewen's "cracked pot" sign on percussion
Vomiting (non-bilious, projectile)

VP Shunt — Post-operative Care

Wound inspection: assess incision site (cranial & abdominal) for redness, swelling, dehiscence, CSF leak
Valve palpation: gently compress and release — should refill within 3–5 seconds (timing varies by shunt type — consult neurosurgery)
Position: gradual position changes; avoid rapid postural drops in ICP; position as directed by neurosurgery
Neurological obs: GCS/AVPU, pupils, fontanelle, OFC — hourly initially
Monitor for over-drainage (slit-ventricle syndrome) and under-drainage

Shunt Malfunction — EMERGENCY Signs

Raised ICP Signs:
• Headache / irritability
• Projectile vomiting
• Altered GCS / drowsiness
• Pupil changes (late)
• Bradycardia + hypertension (Cushing's triad — late)

Shunt Infection:
• Fever (>38°C)
• Redness along shunt tract
• Neck stiffness
• CSF leak from wound
• Lethargy, poor feeding

Nursing Action:
• Immediate medical review
• Maintain airway
• Elevate HOB 30° (unless told otherwise)
• Do NOT pump shunt without neurosurgery instruction
• Prepare for emergency CT / theatre

CCHD Classification

Cyanotic CHD (Right→Left Shunt or Mixing)

Condition	Key Feature
Tetralogy of Fallot (ToF)	VSD + overriding aorta + RVOT obstruction + RVH; "boot-shaped" heart; tet spells
Transposition of Great Arteries (TGA)	Aorta from RV, PA from LV; parallel circulation; ductal/PFO dependent; "egg on a string"
Tricuspid Atresia	No tricuspid valve; obligate ASD + VSD; univentricular pathway
TAPVD	Pulmonary veins drain to systemic circulation; mixed blood only; obstructed form is emergency
Truncus Arteriosus	Single arterial trunk from both ventricles; mixing lesion; CHF early

Acyanotic CHD (Left→Right Shunt)

Condition	Key Feature
VSD	Most common CHD; pan-systolic murmur; small: close spontaneously
ASD	Fixed split S2; often asymptomatic in infancy; ostium secundum most common
PDA	Continuous "machinery" murmur; bounding pulses; common in prematurity
Coarctation of Aorta	BP differential arm vs leg; radio-femoral delay; rib notching on X-ray
Pulmonary Stenosis	Ejection systolic murmur; variable severity; balloon valvuloplasty
Aortic Stenosis	Ejection click; murmur upper RSE; risk of sudden death in severe

SCCHD Screening — Pulse Oximetry Protocol

Universal CCHD screening using pulse oximetry is recommended for all newborns at 24–48 hours of age (post-ductal measurement). Identifies critical CHD before clinical deterioration.

Protocol

Measure SpO₂ on right hand (pre-ductal) AND either foot (post-ductal)

PASS: SpO₂ ≥ 95% in both extremities AND difference ≤ 3% between sites

FAIL: SpO₂ < 90% in either site (immediate referral) OR SpO₂ 90–94% in both OR >3% difference on 3 consecutive measurements (1 hour apart)

Failed screen → urgent echocardiogram; do NOT discharge

Limitations & Nursing Notes

Does NOT detect all CHD (coarctation, obstructed TAPVD may be missed)
Ensure baby is warm, well-perfused, quiet during measurement
Motion artefact — use waveform-confirmed reading
False positive rate low — every failed screen requires echo
Document time, result, and action taken
Discuss results with parents in clear, reassuring language

A normal CCHD screen does NOT exclude all heart disease. Chest auscultation, femoral pulses, and 4-limb BP remain essential physical examination components.

PProstaglandin E1 (PGE1) — Duct-Dependent Circulation

Critical Concept: Duct-dependent lesions rely on a patent ductus arteriosus for either pulmonary blood flow (e.g., pulmonary atresia) or systemic blood flow (e.g., hypoplastic left heart, critical coarctation). PGE1 is life-saving when these lesions are suspected.

Indications & Pharmacology

Duct-dependent pulmonary flow: ToF with pulmonary atresia, tricuspid atresia, pulmonary atresia with intact IVS
Duct-dependent systemic flow: HLHS, critical coarctation, interrupted aortic arch
Mixing lesions: TGA — PGE1 keeps DA open for mixing pending balloon septostomy
Dose: 0.05–0.1 mcg/kg/min IV infusion (start low, titrate)
Effect seen within minutes; duct usually reopens/stays open within 30 min

Nursing Monitoring for PGE1

Apnoea (most critical SE): occurs in 10–12%; have intubation equipment immediately available; ventilatory support ready
Vasodilation / Hypotension: monitor BP every 15–30 min; IV access ×2; fluid bolus if needed
Fever: common; monitor temperature; do not assume sepsis without investigation
Jitteriness/Seizures: rare; monitor neurology
Flushing, oedema: expected side effects
Continuous cardiac monitoring + SpO₂
Document SpO₂ response post-initiation

Never interrupt PGE1 infusion without senior medical instruction — sudden closure of duct in duct-dependent lesion is immediately life-threatening.

SSurgical Interventions Overview

Palliative Procedures

Procedure	Purpose
Modified Blalock-Taussig (BT) Shunt	Subclavian artery → PA; increases pulmonary blood flow in duct-dependent pulmonary conditions; neonatal palliation
Glenn Procedure	SVC → PA; Stage 2 for univentricular hearts (~6 months)
Fontan Procedure	IVC → PA; Stage 3; creates passive pulmonary circulation; ~2–4 years
PA Banding	Limits pulmonary over-circulation in unrestricted VSD/single ventricle

Corrective Procedures

Procedure	Lesion
VSD Closure	Patch closure; complete repair; usually 3–6 months
Arterial Switch Operation	TGA correction; performed in first 2 weeks of life; coronary relocation critical
Total Repair ToF	VSD patch + RVOT reconstruction; 3–12 months
Coarctation Repair	Resection + end-to-end anastomosis / subclavian flap

Post-Cardiac Surgery CICU Nursing

Vasoactive drugs: dopamine, milrinone, noradrenaline — titrate to CI >2.2 L/min/m²
Pacing wires: always labelled; defibrillator at bedside
Coagulation: FFP/platelets/cryoprecipitate post-bypass
Chest drain: hourly outputs; >3ml/kg/hr for 3h = re-explore
Fluid balance: strict hourly; aim slight negative balance on day 2–3
Junctional ectopic tachycardia (JET) — common post-ToF repair; treat hypothermia/electrolytes/pacing

CCleft Lip & Palate

Prevalence: 1 in 700 live births — one of the most common congenital anomalies globally. May occur in isolation or as part of a syndrome (~30% of cases).

Types

Isolated cleft lip (CL): unilateral or bilateral; primary palate only; associated with Pierre Robin sequence and other syndromes
Isolated cleft palate (CP): secondary palate; more likely to be syndrome-associated; affects feeding & speech more
Cleft lip and palate (CLP): combined; most severe feeding difficulty

Pierre Robin Sequence

Micrognathia (small jaw) → tongue displacement (glossoptosis) → posterior cleft palate
Major concern: airway obstruction — prone positioning, nasopharyngeal airway, occasionally tracheostomy
Feeding extremely challenging — cleft team involvement essential

Syndrome Associations

Pierre Robin Sequence Van der Woude Stickler Syndrome 22q11 Deletion Kabuki Syndrome

Associated Anomalies to Screen

Cardiac echo (especially 22q11 deletion)
Hearing assessment — otitis media with effusion very common in CP
Ophthalmology (Stickler syndrome)
Chromosomal microarray if dysmorphic features
Submucosal cleft palate: bifid uvula, zona pellucida, notched hard palate

Feeding — Nursing Care

Positioning:
Keep baby upright (45–90°) during feeds to prevent nasal regurgitation and reduce aspiration risk. Support head. Burp frequently (every 30–60mls).

Specialist Teats:
• NUK (orthodontic) teat — wider base; positions well in mouth
• Squeezable bottles (Haberman/Mead Johnson) — parent controls milk flow
• Breast milk preferred — use expressed breast milk if direct breastfeeding not possible
• Palatal obturator plate — some centres use

Signs of Concern:
• Milk from nose (common — reassure unless excessive)
• Cyanosis or SpO₂ drop during feeding
• Feed taking >30 minutes
• Weight gain <20g/day
• NGT supplementation if inadequate oral intake

Surgical Repair Timing & Post-operative Care

Surgery	Timing	Goal
Cleft lip repair	3–6 months (Rule of 10s: weight ≥10lbs, Hb ≥10g/dL, age ≥10 weeks)	Aesthetic, feeding improvement, nasal reconstruction
Cleft palate repair	9–12 months (before speech development)	Speech, hearing, oral feeding, prevent VPI
Alveolar bone graft	6–9 years (mixed dentition)	Dental support, nasal base
Revision surgery	Adolescence	Aesthetic refinement; orthognathic surgery

Post-operative Nursing (Cleft Repair)

Arm restraints (no-no's): prevent hands/fingers touching repair — apply bilaterally; remove for supervised play; check circulation hourly
No spoon/hard objects in mouth — syringe or soft teat only for feeding
Wound care: gentle cleaning with saline; Vaseline to suture line; keep clean & dry
Monitor for bleeding, wound breakdown, infection
Pain management: regular paracetamol ± ibuprofen; distraction techniques

Multidisciplinary Team

Cleft nurse specialist — key coordinator
Maxillofacial / plastic surgeon
Orthodontist & paediatric dentist
Speech & Language Therapist — early feeding; speech from ~12 months; VPI assessment
ENT — grommets for OME (very common in CP)
Clinical psychologist — body image, school
Genetic counsellor

GGastrointestinal & Thoracic Anomalies

Congenital Diaphragmatic Hernia (CDH)

Bochdalek hernia: posterolateral defect; left-sided 80%; bowel/stomach/liver herniate into thorax
Morgagni hernia: anterior defect; smaller; less severe; often diagnosed later
Pathophysiology: pulmonary hypoplasia (bilateral) + persistent pulmonary hypertension (PPHN)
Immediate management: intubate & ventilate (avoid bag-mask ventilation), NGT to decompress stomach, avoid high pressures
ECMO: extracorporeal membrane oxygenation for refractory respiratory failure — bridge to surgery
Surgical repair: after haemodynamic and respiratory stabilisation (typically 24–72h); primary closure or patch repair

CDH is a surgical emergency but not a neonatal surgical emergency — stabilise first; operate when stable. Immediate surgery worsens outcome.

Abdominal Wall Defects

	Gastroschisis	Omphalocele
Location	Para-umbilical (R side); no sac	Central; sac present (peritoneum)
Contents	Bowel mainly; matted, exposed	Bowel ± liver, spleen
Syndromes	Usually isolated	50% have chromosomal anomaly or syndrome (Beckwith-Wiedemann)
Nursing	Wrap in cling film/saline gauze; keep warm; IV access; decompress stomach	Handle gently; sac may rupture; same wrapping principles

Imperforate Anus

Failure of anal membrane to perforate; low vs high lesions
Examine all neonates: perineal inspection for anal opening and meconium passage within 24–48 hours
Associated with VACTERL — screen for other anomalies
Colostomy for high lesions; primary repair for low lesions

Oesophageal Atresia (OA) / Tracheo-Oesophageal Fistula (TEF)

Types: OA with distal TEF (most common ~85%), isolated OA, isolated TEF (H-type), others
Presentation: excessive oral secretions; choking/cyanosis with first feed; inability to pass NGT beyond 10cm; gas in stomach on X-ray (if fistula present)
3 Cs: Coughing, Choking, Cyanosis with first feed = OA until proven otherwise

Pre-operative: Replogle tube on low continuous suction (removes secretions), head-up position, IV access, nil by mouth, cardiac echo, renal USS
Surgical repair: thoracotomy ± thoracoscopy; primary anastomosis; fistula ligation
Long-term: dysphagia, GORD, tracheomalacia, oesophageal stricture — ongoing surveillance

DDown Syndrome (Trisomy 21)

Prevalence: 1 in 700 live births — most common chromosomal anomaly. Risk increases significantly with advanced maternal age. Consanguinity is NOT a risk factor for Down syndrome.

Characteristic Features

Flat facial profile; upslanting palpebral fissures; epicanthic folds
Brushfield spots (white spots on iris)
Small ears; protruding tongue; single palmar crease (simian crease)
Wide sandal gap (between 1st & 2nd toe)
Hypotonia (universal); joint hypermobility
Short stature; intellectual disability (variable)
5th finger clinodactyly

Cytogenetics

Trisomy 21 (94%): non-disjunction; maternal age related
Translocation (4%): chromosome 21 attached to another (usually 14); recurrence risk depends on carrier parent — may be familial
Mosaic (2%): variable phenotype; often milder features

Health Surveillance Schedule

System	Screening Required	Timing
Cardiac	Echo (CHD in 40-50%: AVSD, VSD, ASD, ToF)	At birth / <1 month
Thyroid	TFT (hypothyroidism common)	Birth, 6m, then annually
Hearing	ABR; OME very common	At birth; annually
Vision	Cataracts, strabismus, nystagmus	At birth; 6-monthly
Coeliac	Anti-TTG IgA antibodies	2–3 years; 5-yearly
Haematology	FBC (leukaemia risk x 20)	At birth; if symptomatic
Atlantoaxial	C-spine X-ray (instability in 15%)	Before sport & surgery
Dementia	Baseline cognitive/memory assessment	From age 30+

Key Exam Point: Down syndrome risk is primarily associated with advanced maternal age (risk at 35 years ~1:350; at 40 years ~1:100; at 45 years ~1:30). Consanguinity increases autosomal RECESSIVE disorders — NOT chromosomal aneuploidies.

CChromosomal Anomalies Comparison

Condition	Karyotype	Key Features	Prognosis/Management
Trisomy 18 (Edwards)	47, +18	IUGR, clenched fists with overlapping fingers, rockerbottom feet, micrognathia, CHD (VSD/ASD), omphalocele; 90% have major CHD	95% die within 1 year; palliative approach standard; parents require extensive counselling; shared decision-making
Trisomy 13 (Patau)	47, +13	Holoprosencephaly, midline facial defects, polydactyly, scalp defects (cutis aplasia), CHD, microphthalmia	Very poor; >80% die in 1st month; palliative care; same ethical approach as T18
Turner Syndrome	45, X0	Short stature, webbed neck, widely spaced nipples, lymphoedema at birth, coarctation of aorta, horseshoe kidney, streak ovaries, primary amenorrhoea, infertility	Oestrogen replacement for puberty induction; growth hormone; fertility counselling; cardiac surveillance; monitor BP (coarctation risk)
Klinefelter Syndrome	47, XXY	Tall stature, small testes, gynaecomastia, sparse body hair, learning difficulties (language), infertility (azoospermia)	Testosterone replacement at puberty; fertility options (TESE/ICSI in some); psychological support

GGenetic Testing & Prenatal Diagnosis

Chromosomal Microarray (CMA)

Detects copy number variants (CNVs) — submicroscopic deletions and duplications
Higher resolution than conventional karyotype — detects ~15-20% additional pathogenic variants in children with structural anomalies
Cannot detect balanced translocations (karyotype still needed for this)
First-line test in children with: developmental delay, multiple anomalies, autism spectrum disorder
Variants of uncertain significance (VOUS) — require careful counselling

Karyotype Indications

Suspected chromosomal syndrome (Down, Turner)
Recurrent pregnancy loss
Parental translocation screening
Ambiguous genitalia

Prenatal Diagnosis Options

Test	Timing	Risk/Limitation
NIPT (cfDNA)	10+ weeks	Screening only; PPV varies; confirm abnormal result with invasive testing
CVS (Chorionic Villus Sampling)	10–14 weeks	~0.5–1% miscarriage risk; earlier result
Amniocentesis	15–20 weeks	~0.1–0.5% miscarriage risk; cytogenetics + microarray + QF-PCR
Fetal anomaly USS	18–22 weeks	Structural survey; operator dependent; nuchal at 11–14 wks

Nursing Role in Genetic Counselling

Non-directive counselling — present information without influencing decision
Ensure informed consent before any invasive test
Provide written information; allow time for questions
Signpost to support groups (Down Syndrome Association, etc.)
Document discussion and decision in notes
Cultural and religious sensitivity — especially in GCC context

GGCC-Specific Context — Congenital Anomalies

Consanguinity in GCC

Consanguineous marriages (first cousins or closer): 25–60% in various Gulf regions
UAE: ~30%; Saudi Arabia: ~35-40%; Qatar/Kuwait/Bahrain: 25-50% (regional variation)
First cousin union: coefficient of relatedness (F) = 0.0625 (1/16)
Significantly increases prevalence of autosomal recessive disorders
Does NOT increase chromosomal anomalies (trisomies)
Background AR disease carrier rates amplified: if both parents are carriers (1/4 chance), risk of affected child = 25%

Recessive Disorders Elevated in GCC

Beta-Thalassaemia Sickle Cell Disease PKU (Phenylketonuria) Organic Acidaemias Congenital Deafness (DFNB1) Congenital Adrenal Hyperplasia Spinal Muscular Atrophy MSUD (Maple Syrup Urine Disease)

Premarital Genetic Screening Programmes

UAE (DHA/DOH): mandatory premarital screening — thalassaemia, SCD, HIV, HBV, HCV; genetic counselling provided
Saudi Arabia: mandatory premarital genetic & infectious disease screening since 2004
Qatar: National premarital medical examination programme
Goal: identify carrier couples, provide counselling, reduce AR disease burden
Programmes show measurable reduction in thalassaemia births in UAE & Saudi Arabia
Nursing role: facilitate screening, explain results, refer to genetic counsellor

NTD in GCC: Prevalence higher in Gulf populations. Folic acid fortification of flour introduced in UAE, Saudi Arabia, Qatar and other GCC states. Combined with preconception supplementation campaigns, NTD rates declining but remain above Western averages.

Maternal Vaccination & Fetal Medicine

Congenital Rubella: near-eliminated in GCC through MMR vaccination programmes; maintain surveillance
Zika virus: not endemic in GCC; risk for returning travellers; microcephaly & NTDs — counsel travellers; delay conception 6 months after potential exposure
Fetal Medicine Centres: established in tertiary hospitals across GCC (King Faisal Specialist Hospital, Hamad Medical, SKMC Abu Dhabi, etc.)
Genetic Counselling Services: developing rapidly; GCC-specific databases being built

DHA / DOH Maternal-Neonatal Guidelines

Universal CCHD pulse oximetry screening — mandated in UAE
Newborn bloodspot screening (expanded panel: PKU, CH, CAH, G6PD, SCD, CF, amino acidopathies in UAE)
Universal hearing screening (UNHS) — mandated
Antenatal Down syndrome screening — first trimester combined + NIPT offered
Folic acid supplementation: 400mcg for all; 5mg for high risk — per UAE MOH guidance
Newborn examination within 24h; discharge check at 6 weeks

EDHA / DOH / SCFHS Exam Prep — High-Yield Points

Must-Know Facts

Folic acid 400mcg standard / 5mg high-risk for NTD prevention
CCHD screening: SpO₂ at 24–48 hours; both pre & post-ductal sites
Down syndrome risk = maternal age (NOT consanguinity)
Consanguinity → autosomal recessive disorders (NOT chromosomal)
PGE1 side effect: APNOEA — intubation equipment must be at bedside
MMC: LATEX-FREE from day 1
VP shunt malfunction: vomiting + irritability + altered GCS
VACTERL: minimum 3 components required for association
Cleft lip repair: 3–6 months; palate repair: 9–12 months
CDH: stabilise FIRST, then operate
Trisomy 18 & 13: palliative approach — share this sensitively
CMA = first-line in multiple anomalies / developmental delay

Common Exam Question Triggers

Q: Newborn with excessive oral secretions and choking on first feed?
→ Oesophageal atresia/TEF. Action: pass NGT (stop at ~10cm), Replogle suction, CXR, refer surgery. Do NOT feed.

Q: Neonate with cardiac lesion on PGE1 becomes apnoeic?
→ Expected PGE1 side effect. Action: airway support, ventilate, DO NOT stop infusion without senior review.

Q: First-cousin parents, previous child with thalassaemia — recurrence risk?
→ 25% (autosomal recessive). Refer for genetic counselling. Premarital screening programme applies in UAE/Saudi.

Q: Best way to prevent NTD in a woman planning pregnancy?
→ Folic acid 400mcg daily from at least 1 month BEFORE conception through first trimester.

Congenital Anomaly Risk Communicator

Enter parental and clinical details to generate a risk summary with recommended investigations and counselling guidance.

Parental Relationship

Previous Affected Child (AR disorder)

Both Parents Known Carriers

Maternal Age (years)

Risk Communication Summary

AR Condition Recurrence Risk

Chromosomal Risk (Maternal Age)

Recommended Investigations

Genetic Counselling Referral

Antenatal Screening Options

This tool provides educational risk estimates only and does not replace clinical genetic counselling. All results should be interpreted by a qualified healthcare professional in the context of full family and clinical history.